Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

  • wallstrsmart wallstrsmart Oct 31, 2013 1:29 PM Flag

    New to Arry!

    Not sure I understand the reason behind the selloff? I read the earnings release and listened to the conference call and thought it was very upbeat! Other than the seasonal tax-loss, any other thoughts?

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Wall

      I am relatively new too. Welcome! The pipeline looks great. I need to research more but will buy on dips.

      Drangles

      • 2 Replies to drangles2000
      • burnaka@sbcglobal.net burnaka Nov 1, 2013 7:46 PM Flag

        drangles if you look at isis and arry charts over a five year span, they look similar until isis took off this year. These companies have similar partner set ups, royalty deals, and even some common partners. The big difference I found was isis has about 100 million more cash, and finally got a drug through the fda to market. It will take a couple years for arry chart to catch the isis chart now, but I got my ticket and have no problem waiting for the train to leave the station. With 4 phase 3 drugs, with more coming in the next 2 years, the real issue for arry is cash burn, and dilution. Getting in early is great when it pays off in the end, tying up cash, well the price one pays.

        If AstraZenica initial phase 3 pans out and the drug gets approved this will be a grand slam because AZ has 37 phase 2 studies for various conditions using the same Mek inhibitor. All I can figure is AZ thinks this inhibitor works on a variety of cancers, and enhances a variety of drugs. Hope they R right.

      • It went down because bio sector didn't perform well for last 3 weeks. Not sure if it's too late for you to wait for the dip now. The way it went up high towards the end doesn't look like it will go below 5. It may go above 6 in a month or so.

        Sentiment: Strong Buy

 
ARRY
6.89-0.13(-1.85%)Jul 2 4:00 PMEDT